Stephens RW - Search Results

1

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.

Nordengren J, Fredstorp Lidebring M, Bendahl PO, Brünner N, Fernö M, Högberg T, Stephens RW, Willén R, Casslén B. Nordengren J, et al. Among authors: stephens rw. Int J Cancer. 2002 Jan 20;97(3):379-85. doi: 10.1002/ijc.1611. Int J Cancer. 2002. PMID: 11774293

2

Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.

Riisbro R, Christensen IJ, Piironen T, Greenall M, Larsen B, Stephens RW, Han C, Høyer-Hansen G, Smith K, Brünner N, Harris AL. Riisbro R, et al. Among authors: stephens rw. Clin Cancer Res. 2002 May;8(5):1132-41. Clin Cancer Res. 2002. PMID: 12006529

3

The urokinase plasminogen activator system as a target for prognostic studies in breast cancer.

Stephens RW, Brünner N, Jänicke F, Schmitt M. Stephens RW, et al. Breast Cancer Res Treat. 1998;52(1-3):99-111. doi: 10.1023/a:1006115218786. Breast Cancer Res Treat. 1998. PMID: 10066075 Review.

4

The complex between urokinase and its type-1 inhibitor in primary breast cancer: relation to survival.

Pedersen AN, Christensen IJ, Stephens RW, Briand P, Mouridsen HT, Danø K, Brünner N. Pedersen AN, et al. Among authors: stephens rw. Cancer Res. 2000 Dec 15;60(24):6927-34. Cancer Res. 2000. PMID: 11156392

5

High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.

Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, Brünner N. Holten-Andersen MN, et al. Among authors: stephens rw. Clin Cancer Res. 2000 Nov;6(11):4292-9. Clin Cancer Res. 2000. PMID: 11106246

6

The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients.

Sier CF, Stephens R, Bizik J, Mariani A, Bassan M, Pedersen N, Frigerio L, Ferrari A, Danø K, Brünner N, Blasi F. Sier CF, et al. Cancer Res. 1998 May 1;58(9):1843-9. Cancer Res. 1998. PMID: 9581823

7

Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer.

Holten-Andersen MN, Christensen IJ, Nielsen HJ, Stephens RW, Jensen V, Nielsen OH, Sørensen S, Overgaard J, Lilja H, Harris A, Murphy G, Brünner N. Holten-Andersen MN, et al. Among authors: stephens rw. Clin Cancer Res. 2002 Jan;8(1):156-64. Clin Cancer Res. 2002. PMID: 11801553

8

The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer.

Brünner N, Nielsen HJ, Hamers M, Christensen IJ, Thorlacius-Ussing O, Stephens RW. Brünner N, et al. Among authors: stephens rw. APMIS. 1999 Jan;107(1):160-7. doi: 10.1111/j.1699-0463.1999.tb01539.x. APMIS. 1999. PMID: 10190293 Review.

9

Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis.

Stephens RW, Nielsen HJ, Christensen IJ, Thorlacius-Ussing O, Sørensen S, Danø K, Brünner N. Stephens RW, et al. J Natl Cancer Inst. 1999 May 19;91(10):869-74. doi: 10.1093/jnci/91.10.869. J Natl Cancer Inst. 1999. PMID: 10340907

10

Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies.

Holst-Hansen C, Hamers MJ, Johannessen BE, Brünner N, Stephens RW. Holst-Hansen C, et al. Among authors: stephens rw. Br J Cancer. 1999 Sep;81(2):203-11. doi: 10.1038/sj.bjc.6690678. Br J Cancer. 1999. PMID: 10496343 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters